OTTAWA, ON (May 26, 2017) – The Honourable Carolyn Bennett, Minister of Indigenous and Northern Affairs, and the Honourable Jane Philpott, Minister of Health, issued the following statement today:
Health Canada is introducing several improvements to its medical cannabis program that aim to streamline the application process for issuing production licenses and enable increased production under the Access to Cannabis for Medical Purposes Regulations (ACMPR).
Health Canada is introducing several improvements that aim to streamline the licensing of medical cannabis producers and enable increased production of cannabis.
The Honourable Jane Philpott, Minister of Health, will lead the Canadian delegation to both the G20 Health Ministers' Meeting (HMM) in Berlin, Germany, and the 70th World Health Assembly (WHA) in Geneva, Switzerland.
On May 18, 2017, Bill C-37, an Act to amend the Controlled Drugs and Substances Act and to make related amendments to other Acts, received Royal Assent and became law.
On May 18, 2017, Bill C-37, an Act to amend the Controlled Drugs and Substances Act and to make related amendments to other Acts, received Royal Assent and became law.
On May 18, 2017, Bill C-37 - An Act to amend the Controlled Drugs and Substances Act and to make related amendments to other Acts, received Royal Assent and became law.
Today, Health Canada announced new rules for veterinary drugs that will better protect Canadians against AMR; these changes to the Food and Drug Regulations have been published in the Canada Gazette, Part II.